Article Versions Notes

Grottoli M, Carrega P, Zullo L, Dellepiane C, Rossi G, Parisi F, Barletta G, Zinoli L, Coco S, Alama A, et al. Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers. 2022; 14(20):5046. https://doi.org/10.3390/cancers14205046

Grottoli, Melania, Paolo Carrega, Lodovica Zullo, Chiara Dellepiane, Giovanni Rossi, Francesca Parisi, Giulia Barletta, Linda Zinoli, Simona Coco, Angela Alama, and et al. 2022. "Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy" Cancers 14, no. 20: 5046. https://doi.org/10.3390/cancers14205046

Grottoli, M., Carrega, P., Zullo, L., Dellepiane, C., Rossi, G., Parisi, F., Barletta, G., Zinoli, L., Coco, S., Alama, A., Marconi, S., Parodi, M., Orecchia, P., Bassi, S., Vitale, M., Mingari, M. C., Pfeffer, U., Genova, C., & Pietra, G. (2022). Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers, 14(20), 5046. https://doi.org/10.3390/cancers14205046